Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Financial Statement Detail

v3.22.2
Condensed Consolidated Financial Statement Detail
6 Months Ended
Jun. 30, 2022
Condensed Consolidated Financial Statement Detail  
Condensed Consolidated Financial Statement Detail

3. Condensed Consolidated Financial Statements Details

Equity Securities

As of June 30, 2022 and December 31, 2021, equity securities consisted of an investment in Rezolute’s common stock of $0.5 million and $0.8 million, respectively (Note 4). For the three and six months ended June 30, 2022, the Company recognized a loss of $25,000 and $0.3 million, respectively, due to the change in fair value of its investment in Rezolute’s common stock in the other income (expense), net line item of the condensed consolidated statements of operations and comprehensive loss. For the three and six months ended June 30, 2021, the Company recognized a gain of $1.3 million and $0.6 million, respectively, due to the change in fair value of its investment.

Accrued and Other Liabilities

Accrued and other liabilities consisted of the following (in thousands):

June 30, 

December 31, 

    

2022

    

2021

Accrued incentive compensation

461

55

Accrued legal and accounting fees

424

295

Accrued payroll and benefits

 

121

 

135

Other accrued liabilities

20

40

Total

$

1,026

$

525

Net Loss Per Share Attributable to Common Stockholders

The following is a reconciliation of the numerator (net loss) and the denominator (number of shares) used in the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share amounts):

Three Months Ended June 30, 

Six Months Ended June 30, 

    

2022

    

2021

    

2022

    

2021

Numerator

 

  

 

  

 

  

 

  

Net loss

$

(4,670)

$

(2,237)

$

(6,950)

$

(9,610)

Less: Series A accumulated dividends

 

(530)

 

(530)

 

(1,061)

 

(1,061)

Less: Series B accumulated dividends

(838)

(763)

(1,675)

(763)

Net loss attributable to common stockholders, basic and diluted

$

(6,038)

$

(3,530)

$

(9,686)

$

(11,434)

 

 

Denominator

 

 

 

 

Weighted average shares used in computing basic and diluted net loss per share attributable to common stockholders

 

11,421

11,285

 

11,376

 

11,263

Basic and diluted net loss per share attributable to common stockholders

$

(0.53)

(0.31)

$

(0.85)

$

(1.02)

Potentially dilutive securities are excluded from the calculation of diluted net loss per share attributable to common stockholders if their inclusion is anti-dilutive.

The following table shows the weighted-average shares from outstanding securities considered anti-dilutive and therefore excluded from the computation of diluted net loss per share attributable to common stockholders (in thousands):

Three Months Ended June 30, 

Six Months Ended June 30, 

    

2022

    

2021

    

2022

    

2021

Convertible preferred stock

5,003

5,003

5,003

5,003

Common stock options

 

889

 

377

 

813

318

Warrants for common stock

 

6

 

5

 

6

5

Total

 

5,898

 

5,385

 

5,822

 

5,326